Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
148,2 EUR | -0,30% | +0,30% | +21,79% |
08:50 | Astra krijgt goedkeuring voor medicijn in VS; Ascential handelt in lijn | AN |
08:35 | AstraZeneca krijgt goedkeuring van de Amerikaanse FDA voor behandeling van endometriumkanker | MT |
Vakgebied
- productverkoop (95,6%). De nettoverkoop wordt per behandelingsgebied verdeeld tussen oncologie (39,2%), hart- en vaatziekten, nierziekten en stofwisselingsziekten (24,2%), ademhalings- en auto-immuunziekten (13,9%), en overige (22,7%; ontstekingsziekten, neurologische ziekten, maag-, darm- en infectieziekten);
- inkomsten uit samenwerking (4,4%).
De netto-omzet is als volgt geografisch verdeeld: het Verenigd Koninkrijk (7,4%), Europa (21,2%), Amerika (45,3%) en Afrika-Azië-Australië (26,1%).
Aantal werknemers: 89 900
Verkoop per activiteit
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Oncology
37,4
%
| 11 878 | 33,0 % | 13 793 | 37,4 % | +16,12% |
Cardiovascular, Renal and Metabolism
23,1
%
| 7 459 | 20,7 % | 8 515 | 23,1 % | +14,16% |
Rare Disease
16,9
%
| 5 726 | 15,9 % | 6 246 | 16,9 % | +9,08% |
Respiratory and Immunology
13,3
%
| 4 680 | 13,0 % | 4 913 | 13,3 % | +4,97% |
Alliance
3,1
%
| - | - | 1 149 | 3,1 % | - |
Other Medicines
2,6
%
| 1 319 | 3,7 % | 946 | 2,6 % | -28,29% |
Vaccines and Immune Therapies
2,2
%
| 3 845 | 10,7 % | 814 | 2,2 % | -78,83% |
Collaboration
1,3
%
| 1 098 | 3,1 % | 478 | 1,3 % | -56,50% |
Verkoop per regio
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
39,6
%
| 14 027 | 39,0 % | 14 578 | 39,6 % | +3,93% |
China
12,8
%
| 4 662 | 12,9 % | 4 724 | 12,8 % | +1,32% |
Japan
7,9
%
| 3 236 | 9,0 % | 2 928 | 7,9 % | -9,51% |
United Kingdom
7,4
%
| 2 530 | 7,0 % | 2 709 | 7,4 % | +7,07% |
Other Rest of Europe
6,8
%
| 2 197 | 6,1 % | 2 502 | 6,8 % | +13,89% |
Germany
4,6
%
| 1 544 | 4,3 % | 1 689 | 4,6 % | +9,36% |
Other Asia, Africa and Australasia
4,5
%
| 1 953 | 5,4 % | 1 645 | 4,5 % | -15,77% |
Sweden
3,7
%
| 1 397 | 3,9 % | 1 371 | 3,7 % | -1,89% |
Other Americas
3,7
%
| 954 | 2,6 % | 1 354 | 3,7 % | +41,94% |
France
2,5
%
| 899 | 2,5 % | 927 | 2,5 % | +3,12% |
Canada
2,1
%
| 947 | 2,6 % | 778 | 2,1 % | -17,82% |
Spain
1,8
%
| 599 | 1,7 % | 681 | 1,8 % | +13,73% |
Italy
1,8
%
| 597 | 1,7 % | 654 | 1,8 % | +9,61% |
Australia
0,9
%
| 464 | 1,3 % | 314 | 0,9 % | -32,32% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 64 | 01-10-12 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 01-08-21 |
Sharon Barr
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-23 |
Regina Danielson
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Cindy Hoots
CTO | Chief Tech/Sci/R&D Officer | 56 | 01-01-20 |
Jeffrey Pott
CMP | Compliance Officer | - | 01-01-95 |
Chief Tech/Sci/R&D Officer | - | 18-05-23 | |
Pam Cheng
COO | Chief Operating Officer | 53 | 01-06-15 |
Iskra Reic
PRN | Corporate Officer/Principal | - | 01-01-01 |
Sjoerd Hubben
LAW | General Counsel | - | 01-03-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sherilyn McCoy
BRD | Director/Board Member | 65 | 01-10-17 |
Philip Broadley
BRD | Director/Board Member | 63 | 27-04-17 |
Director/Board Member | 68 | 01-04-99 | |
Marc Dunoyer
PRN | Corporate Officer/Principal | 71 | 01-06-13 |
Andreas Rummelt
BRD | Director/Board Member | 67 | 01-08-21 |
Michel Demaré
CHM | Chairman | 67 | 01-09-19 |
Pascal Soriot
CEO | Chief Executive Officer | 64 | 01-10-12 |
Deborah DiSanzo
BRD | Director/Board Member | 64 | 01-12-17 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 01-08-21 |
Shu Kam Mok
BRD | Director/Board Member | 63 | 01-01-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 550 256 302 | 1 498 113 319 ( 96,64 %) | 0 | 96,64 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
18 750 000 | 75.00% | 1 384 260 375 $ | |
35 043 624 | 9.89% | 940 965 109 $ | |
108 923 023 | 37.58% | 593 182 802 $ | |
NIOX GROUP PLC 16.76% | 71 065 878 | 16.76% | 63 879 696 $ |
CELLECTIS S.A. 22.30% | 16 000 000 | 22.30% | 41 860 800 $ |
INNATE PHARMA 9.26% | 7 485 500 | 9.26% | 20 559 450 $ |
44 803 | 3.39% | 454 750 $ | |
884 956 | 1.99% | 54 867 $ |
Bedrijfsgegevens
AstraZeneca PLC
Cambridge Biomedical Campus 1 Francis Crick Avenue
CB2 0AA, Cambridge
+44 20 3749 5000
http://www.astrazeneca.co.ukBedrijven van de groep
Naam | Categorie en sector |
---|---|
R&Q Beta Co. Plc
R&Q Beta Co. Plc Insurance Brokers/ServicesFinance R&Q Beta Co. Plc provides insurance services. The company was founded in 1994 and is headquartered in Cambridge, the United Kingdom. |
Insurance Brokers/Services
|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. |
Miscellaneous Commercial Services
|
Alexion Pharmaceuticals, Inc. /New/
| |
Astrazeneca Finance & Holdings, Inc.
Astrazeneca Finance & Holdings, Inc. Financial ConglomeratesFinance Part of AstraZeneca PLC, Astrazeneca Finance & Holdings, Inc. is an investment holding American company. The company is located in the US. |
Financial Conglomerates
|
AstraZeneca India Pvt Ltd.
AstraZeneca India Pvt Ltd. Pharmaceuticals: MajorHealth Technology AstraZeneca India Pvt Ltd. operates as a biopharmaceutical company. The company was founded in 1979 and is headquartered in Bangalore, India. |
Pharmaceuticals: Major
|
Astrazeneca Treasury Ltd.
Astrazeneca Treasury Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca Treasury Ltd. functions as an investment holding British company. The company is based in Cambridge, UK. |
Financial Conglomerates
|
Astrazeneca Holdings BV
| |
Astrazeneca Treasury BV
| |
AstraZeneca Employee Share Trust Ltd.
AstraZeneca Employee Share Trust Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AstraZeneca PLC, AstraZeneca Employee Share Trust Ltd. is a British company that provides business support services. The company is located in the UK. |
Miscellaneous Commercial Services
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,96% | 630 mld. | |
-7,15% | 350 mld. | |
+18,77% | 328 mld. | |
+8,79% | 298 mld. | |
+1,27% | 225 mld. | |
+11,95% | 218 mld. | |
+3,68% | 160 mld. | |
-4,38% | 156 mld. | |
-3,72% | 116 mld. |